{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:08:31Z","timestamp":1794049711471,"version":"4.8.0"},"reference-count":29,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,10,4]]},"DOI":"10.3233\/jad-160533","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T14:37:19Z","timestamp":1471358239000},"page":"903-912","source":"Crossref","is-referenced-by-count":65,"title":["Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model"],"prefix":"10.1177","volume":"54","author":[{"given":"Ester","family":"Aso","sequence":"first","affiliation":[{"name":"Institut de Neuropatologia, Servei d\u2019Anatomia Patol\u00f2gica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, L\u2019Hospitalet de Llobregat, Spain"},{"name":"CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto Carlos III, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pol","family":"Andr\u00e9s-Benito","sequence":"additional","affiliation":[{"name":"Institut de Neuropatologia, Servei d\u2019Anatomia Patol\u00f2gica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, L\u2019Hospitalet de Llobregat, Spain"},{"name":"CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto Carlos III, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[{"name":"Institut de Neuropatologia, Servei d\u2019Anatomia Patol\u00f2gica, IDIBELL-Hospital Universitari de Bellvitge, Universitat de Barcelona, L\u2019Hospitalet de Llobregat, Spain"},{"name":"CIBERNED, Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Neurodegenerativas, Instituto Carlos III, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-160533_ref1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2012.03.005","article-title":"Defining Alzheimer as a common age-related neurodegenerative process not inevitably leading to dementia","volume":"97","author":"Ferrer","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-160533_ref2","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1126\/science.1228541","article-title":"Preventing Alzheimer\u2019s disease","volume":"337","author":"Selkoe","year":"2012","journal-title":"Science"},{"key":"10.3233\/JAD-160533_ref3","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/sj.bjp.0707446","article-title":"Alzheimer\u2019s disease; taking the edge off with cannabinoids?","volume":"152","author":"Campbell","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-160533_ref4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3233\/JAD-2008-15315","article-title":"Targeting the endocannabinoid system in Alzheimer\u2019s disease","volume":"15","author":"Koppel","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2014.00037","article-title":"Cannabinoids for treatment of Alzheimer\u2019s disease: Moving toward the clinic","volume":"5","author":"Aso","year":"2014","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-160533_ref6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3233\/JAD-141635","article-title":"The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer\u2019s disease","volume":"43","author":"Bedse","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref7","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-160533_ref8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3233\/JAD-2012-111862","article-title":"CB1 agonist ACEA protects neurons and reduces the cognitive impairment of A\u03b2PP\/PS1 mice","volume":"30","author":"Aso","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3233\/JAD-130137","article-title":"CB2 cannabinoid receptor agonist ameliorates Alzheimer-like phenotype in A\u03b2PP\/PS1 mice","volume":"35","author":"Aso","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-9-8","article-title":"Prolonged oral cannabinoid administration prevents neuroinflammation, lowers \u03b2-amyloid levels and improves cognitive performance in Tg APP 2576 mice","volume":"9","author":"Mart\u00edn-Moreno","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-160533_ref11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.neurobiolaging.2012.06.011","article-title":"Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency","volume":"34","author":"Wu","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160533_ref12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3233\/JAD-130050","article-title":"Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy","volume":"35","author":"Casarejos","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-141014","article-title":"Cannabis-based medicine reduces multiple pathological processes in A\u03b2PP\/PS1 mice","volume":"43","author":"Aso","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref14","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"10.3233\/JAD-160533_ref15","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-160533_ref16","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1007\/s00213-014-3478-5","article-title":"Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe\/PS1\u0394E9 mice","volume":"231","author":"Cheng","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-160533_ref17","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-140921","article-title":"Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer\u2019s disease transgenic mice","volume":"42","author":"Cheng","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-160533_ref18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cell.2013.10.042","article-title":"\u03949-THC-caused synaptic and memory impairments are mediated through COX-2 signaling","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.3233\/JAD-160533_ref19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/brain\/awr046","article-title":"Molecular reorganization of endocannabinoid signalling in Alzheimer\u2019s disease","volume":"134","author":"Mulder","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-160533_ref20","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.neuropharm.2004.08.009","article-title":"Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats","volume":"47","author":"Fadda","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-160533_ref21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1101\/cshperspect.a012237","article-title":"Synaptic targets of \u03949-tetrahydrocannabinol in the central nervous system","volume":"3","author":"Hoffman","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.3233\/JAD-160533_ref22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-160533_ref23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00005072-199803000-00002","article-title":"Dystrophic neurites of senile plaques are defective in proteins involved in exocytosis and neurotransmission","volume":"57","author":"Ferrer","year":"1998","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-160533_ref24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.neurobiolaging.2014.04.001","article-title":"Amyloid-\u03b2 alters ongoing neuronal activity and excitability in the frontal cortex","volume":"35","author":"Kellner","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-160533_ref25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.pneurobio.2012.07.001","article-title":"Brain excitability and connectivity of neuronal assemblies in Alzheimer\u2019s disease: From animal models to human findings","volume":"99","author":"D\u2019Amelio","year":"2012","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-160533_ref26","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neuron.2014.04.039","article-title":"beta-amyloid inhibits E-S potentiation through suppression of cannabinoid receptor 1-dependent synaptic disinhibition","volume":"82","author":"Orr","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-160533_ref27","doi-asserted-by":"crossref","first-page":"11256","DOI":"10.1073\/pnas.1016442108","article-title":"Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging","volume":"108","author":"Albayram","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-160533_ref28","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2016.03.010","article-title":"Effect of cannabis on glutamate signalling in the brain, A systematic review of human and animal evidence","volume":"64","author":"Colizzi","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-160533_ref29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1352458510367462","article-title":"Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis","volume":"16","author":"Wade","year":"2010","journal-title":"Mult Scler"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-160533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:01Z","timestamp":1777370641000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-160533"}},"subtitle":[],"editor":[{"given":"Tommaso","family":"Cassano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,10,4]]},"references-count":29,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-160533","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,4]]}}}